WHLR
$1.38
Wheeler Real Estate Investment Trust, Inc.
Recent News
Wheeler Real Estate: Q4 Earnings Snapshot
The Virginia Beach, Virginia-based real estate investment trust said it had funds from operations of $3.2 million, or $9.96 per share, in the period. Funds from operations is a closely watched measure in the REIT industry. It takes net income and adds back items such as depreciation and amortization.
Denison Mines (DNN) Closes Russell Lake Joint Venture with Skyharbour
The share price of Denison Mines Corp. (NYSEAMERICAN:DNN) surged by 4.98% between December 12 and December 19, 2025, putting it among the Energy Stocks that Gained the Most This Week. Denison Mines Corp. (NYSEAMERICAN:DNN) is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. Denison Mines […]
Roth MKM Asserts Buy Rating on Denison Mines Corp. (DNN) as Uranium Production Surge
Denison Mines Corp (NYSE:DNN) is one of the best mid cap stocks to buy according to hedge funds. On November 11, Roth MKM analyst Joseph Reagor reiterated a Buy rating on Denison Mines Corp (NYSE:DNN) and set a $3 price target. This came after the company declared third-quarter results on November 6, which showed progress […]
Wheeler Real Estate: Q3 Earnings Snapshot
WHLR) on Thursday reported a key measure of profitability in its third quarter. The Virginia Beach, Virginia-based real estate investment trust said it had funds from operations of $2 million, or $4.20 per share, in the period. Funds from operations is a closely watched measure in the REIT industry.
A Look at Mitsubishi (TSE:8058) Valuation Following Strategic Biotech Deal with Wheeler Bio
Mitsubishi (TSE:8058) has taken another step into the biotech sector by announcing a strategic partnership with Wheeler Bio focused on expanding commercial opportunities across the Asia-Pacific region. The collaboration includes a direct investment in Wheeler’s latest funding round. See our latest analysis for Mitsubishi. Mitsubishi’s renewed push into biotech comes on the back of strong market momentum. The past three months alone saw a 22.6% rise in share price, with the 2024 year-to-date...